» Articles » PMID: 29925834

Urinary Cell-free DNA is a Versatile Analyte for Monitoring Infections of the Urinary Tract

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Jun 22
PMID 29925834
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Urinary tract infections are one of the most common infections in humans. Here we tested the utility of urinary cell-free DNA (cfDNA) to comprehensively monitor host and pathogen dynamics in bacterial and viral urinary tract infections. We isolated cfDNA from 141 urine samples from a cohort of 82 kidney transplant recipients and performed next-generation sequencing. We found that urinary cfDNA is highly informative about bacterial and viral composition of the microbiome, antimicrobial susceptibility, bacterial growth dynamics, kidney allograft injury, and host response to infection. These different layers of information are accessible from a single assay and individually agree with corresponding clinical tests based on quantitative PCR, conventional bacterial culture, and urinalysis. In addition, cfDNA reveals the frequent occurrence of pathologies that remain undiagnosed with conventional diagnostic protocols. Our work identifies urinary cfDNA as a highly versatile analyte to monitor infections of the urinary tract.

Citing Articles

Microbiological Diagnostic Performance and Clinical Effect of Metagenomic Next-Generation Sequencing for the Detection of Immunocompromised Patients With Community-Acquired Pneumonia.

Zheng H, Peng P, Wang S, Zhang B, Yang L, Wang Y Infect Drug Resist. 2025; 18:1223-1236.

PMID: 40052063 PMC: 11883178. DOI: 10.2147/IDR.S462358.


Urinary Tract Infections Detection with Molecular Biomarkers.

Sun J, Cheng K, Xie Y Biomolecules. 2025; 14(12.

PMID: 39766247 PMC: 11673847. DOI: 10.3390/biom14121540.


Multi-Omics Profiling Unveils the Complexity and Dynamics of Immune Infiltrates in Intrahepatic Cholangiocarcinoma.

Li X, Wang Y, Guan R, Sheng N, Zhang S Biology (Basel). 2024; 13(10).

PMID: 39452125 PMC: 11504529. DOI: 10.3390/biology13100816.


Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.

Cao C, Yuan L, Wang Y, Liu H, Cuello Garcia H, Huang H Front Immunol. 2024; 15:1435578.

PMID: 39308855 PMC: 11412870. DOI: 10.3389/fimmu.2024.1435578.


Exploring the clinical and diagnostic value of metagenomic next-generation sequencing for urinary tract infection: a systematic review and meta-analysis.

He S, Liu H, Hu X, Zhao J, Liang J, Zhang X BMC Infect Dis. 2024; 24(1):1000.

PMID: 39294577 PMC: 11412013. DOI: 10.1186/s12879-024-09914-9.


References
1.
Hart A, Smith J, Skeans M, Gustafson S, Stewart D, Cherikh W . OPTN/SRTR 2015 Annual Data Report: Kidney. Am J Transplant. 2017; 17 Suppl 1:21-116. PMC: 5527691. DOI: 10.1111/ajt.14124. View

2.
Mollerup S, Friis-Nielsen J, Vinner L, Hansen T, Richter S, Fridholm H . Propionibacterium acnes: Disease-Causing Agent or Common Contaminant? Detection in Diverse Patient Samples by Next-Generation Sequencing. J Clin Microbiol. 2016; 54(4):980-7. PMC: 4809928. DOI: 10.1128/JCM.02723-15. View

3.
Lo Y, Tein M, Pang C, Yeung C, Tong K, Hjelm N . Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet. 1998; 351(9112):1329-30. DOI: 10.1016/s0140-6736(05)79055-3. View

4.
Kent W . BLAT--the BLAST-like alignment tool. Genome Res. 2002; 12(4):656-64. PMC: 187518. DOI: 10.1101/gr.229202. View

5.
Bettegowda C, Sausen M, Leary R, Kinde I, Wang Y, Agrawal N . Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014; 6(224):224ra24. PMC: 4017867. DOI: 10.1126/scitranslmed.3007094. View